Roche Announces FDA Approval of One of the First HPV Self-collection Solutions in the U.S., Expanding Access and Screening Options to Help Eliminate Cervical Cancer

Yahoo FinanceMay 15 01:00 ET

Sarepta Upgraded at Oppenheimer on Potential Elevidys Label Expansion

Seeking AlphaMay 14 09:00 ET

TG Therapeutics Wins VA Contract for Briumvi

Seeking AlphaApr 18 13:15 ET

Roche's Multiple Sclerosis Injection Controls Relapses, Brain Lesions in Late-stage Trial

Roche (ROG.SW, RO.SW) on Wednesday said the subcutaneous formula of Ocrevus showed nearly complete suppression of clinical relapses and brain lesions in multiple sclerosis patients at 48 weeks, citing updated late-stage data.

MT NewswiresApr 17 05:47 ET

[Ad Hoc Announcement Pursuant to Art. 53 LR] Roche's Columvi Meets Primary Endpoint of Overall Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma in Phase III STARGLO Study

Yahoo FinanceApr 15 01:00 ET

Adaptimmune Slips as Roche Strategic Collaboration Ends

Seeking AlphaApr 12 08:53 ET